| Catalog No. | VK515056 |
| Host species | Human |
| Species reactivity | Influenza B virus |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgG1, kappa |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Target | HA/Hemagglutinin |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | Please contact the lab for this information. |
| Expression system | Mammalian Cells |
| Accession | P03461 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternative name | RG6024, RG6024, MHAB5553A, RG70026, RO7045557, 1807960-57-1 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Research Grade Lesofavumab
Overview
Description
Lesofavumab is a recombinant monoclonal antibody to Influenza B virus hemagglutinin. Lesofavumab is a human monoclonal antibody that can be potentially used in the treatment of Influenza B infection. Genentech, a subsidiary of Roche, is developing Lesofavumab (RG6024), a monoclonal antibody, for the treatment of influenza B infections.
Images
 Bioactivity |
SEC-HPLC detection for Research Grade Lesofavumab. |
 SDS-PAGE |
SDS-PAGE for Research Grade Lesofavumab. |